Home BEAT BioTherapeutics

BEAT BioTherapeutics

In operation
Seed Round Financing
A company developing novel therapies for heart disease

Basic Information

BEAT BioTherapeutics (BEATBio) is a biotechnology company located in Seattle, Washington, dedicated to developing new therapies for heart disease. BEAT Bio's first product is based on fundamental discoveries in myocardial contraction and the development of novel Gene Therapy to improve cardiac function in heart failure.
BEAT BioTherapeutics
Washington,United States of America
less than 15 people
January 01, 2008
mkranda@beatbiotherapeutics.com